A Phase Ib Study Of Troriluzole (Bhv-4157) In Combination With Nivolumab

JOURNAL OF CLINICAL ONCOLOGY(2020)

引用 3|浏览44
暂无评分
摘要
79Background: The Metabotropic Glutamate Receptor 1 (GRM1) is overexpressed in many solid tumors. It activates MAPK and PI3K/AKT pathways and promotes an immune-suppressive tumor microenvironment. ...
更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要